EMAIL THIS PAGE TO A FRIEND

PloS one

Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assay.


PMID 25343249

Abstract

Chloroquine was a cheap, extremely effective drug against Plasmodium falciparum until resistance arose. One approach to reversing resistance is the inhibition of chloroquine efflux from its site of action, the parasite digestive vacuole. Chloroquine accumulation studies have traditionally relied on radiolabelled chloroquine, which poses several challenges. There is a need for development of a safe and biologically relevant substitute. We report here a commercially-available green fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a proxy for chloroquine accumulation. This compound localized to the digestive vacuole of the parasite as observed under confocal microscopy, and inhibited growth of chloroquine-sensitive strain 3D7 more extensively than in the resistant strains 7G8 and K1. Microplate reader measurements indicated suppression of LynxTag-CQGREEN efflux after pretreatment of parasites with known reversal agents. Microsomes carrying either sensitive- or resistant-type PfCRT were assayed for uptake; resistant-type PfCRT exhibited increased accumulation of LynxTag-CQGREEN, which was suppressed by pretreatment with known chemosensitizers. Eight laboratory strains and twelve clinical isolates were sequenced for PfCRT and Pgh1 haplotypes previously reported to contribute to drug resistance, and pfmdr1 copy number and chloroquine IC50s were determined. These data were compared with LynxTag-CQGREEN uptake/fluorescence by multiple linear regression to identify genetic correlates of uptake. Uptake of the compound correlated with the logIC50 of chloroquine and, more weakly, a mutation in Pgh1, F1226Y.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C3025
(±)-Chlorpheniramine maleate salt, ≥99% (perchloric acid titration)
C16H19ClN2 · C4H4O4
V4629
(±)-Verapamil hydrochloride, ≥99% (titration), powder
C27H38N2O4 · HCl
PHR1131
(±)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
C27H38N2O4 · HCl
C1800000
Chlorphenamine maleate, European Pharmacopoeia (EP) Reference Standard
C16H19ClN2 · C4H4O4
1123000
Chlorpheniramine maleate, United States Pharmacopeia (USP) Reference Standard
C16H19ClN2 · C4H4O4
PHR1016
Chlorpheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
C16H19ClN2 · C4H4O4
C8138
Chlorpromazine hydrochloride, ≥98% (TLC)
C17H19ClN2S · HCl
C0982
Chlorpromazine hydrochloride, meets USP testing specifications
C17H19ClN2S · HCl
C1900000
Chlorpromazine hydrochloride, European Pharmacopoeia (EP) Reference Standard
C17H19ClN2S · HCl
1125006
Chlorpromazine hydrochloride, United States Pharmacopeia (USP) Reference Standard
C17H19ClN2S · HCl
31679
Chlorpromazine hydrochloride, VETRANAL, analytical standard
C17H19ClN2S · HCl
C1671
Chlorprothixene hydrochloride
C18H18ClNS · HCl
C1915000
Chlorprothixene hydrochloride, European Pharmacopoeia (EP) Reference Standard
C18H18ClNS · HCl
D3900
Desipramine hydrochloride, ≥98% (TLC), powder
C18H22N2 · HCl
D0500000
Desipramine hydrochloride, European Pharmacopoeia (EP) Reference Standard
C18H22N2 · HCl
1172006
Desipramine hydrochloride, United States Pharmacopeia (USP) Reference Standard
C18H22N2 · HCl
D-906
Desipramine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
C18H23ClN2
L4762
Loperamide hydrochloride
C29H33ClN2O2 · HCl
34014
Loperamide hydrochloride, VETRANAL, analytical standard
C29H33ClN2O2 · HCl
L0750000
Loperamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
C29H33ClN2O2 · HCl
1370000
Loperamide hydrochloride, United States Pharmacopeia (USP) Reference Standard
C29H33ClN2O2 · HCl
PHR1162
Loperamide hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
C29H33ClN2O2 · HCl
Y0000322
Loperamide hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
C29H33ClN2O2 · HCl
M149
Methiothepin mesylate salt, ≥98% (HPLC), solid
C20H24N2S2 · CH4O3S
M5441
Mibefradil dihydrochloride hydrate, ≥98% (HPLC), powder
C29H38FN3O3 · 2HCl · xH2O
O111
Octoclothepin maleate salt, solid
C19H21ClN2S · C4H4O4
Y0000797
Promethazine for peak identification, European Pharmacopoeia (EP) Reference Standard
C17H20N2S · HCl
P4651
Promethazine hydrochloride
C17H20N2S · HCl
46682
Promethazine hydrochloride, VETRANAL, analytical standard
C17H20N2S · HCl
P-044
Promethazine hydrochloride, vial of 25 mg, certified reference material
C17H20N2S · HCl